A study recently undertaken and published by the Oxford Academic Health Science Network (AHSN) has shown that Horiba’s Microsemi CRP point-of-care testing (POCT) analyser facilitates more rapid clinical decision-making, saving time and reducing costs, in emergency paediatric units. The study found that using POCT as a replacement for laboratory tests resulted in earlier decision-making in approximately 75% of cases across three hospital sites. Economic analysis across these sites found that this could result in net annual cost savings due to reduced staff time, as well as faster decisions on antibiotic use.
The multi-site evaluation study was undertaken in emergency paediatric units at John Radcliffe Hospital (Oxford), Stoke Mandeville Hospital (Aylesbury) and Wexham Park Hospital (Slough) with the aim of assessing if POCT in such units could improve quality of care. The AHSN selected Horiba’s Microsemi CRP as the POC device for evaluation as it is an automated analyser able to measure C-reactive protein (CRP) with full blood count simultaneously. Both parameters are commonly used in conjunction in paediatric emergency care to assist with clinical decision-making, with CRP being a proxy indicator for presence or absence of bacterial infection.
www.horiba.com/uk/medical/news-events/news/article/study-confirms-horiba-poct-analyser-enables-earlier-clinical-decision-making-in-emergency-paediatrics-53419/
